• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

皮质类固醇在免疫功能正常患者急性眼部弓形虫病治疗中的作用:一例报告

The Role of Corticosteroids in Treating Acute Ocular Toxoplasmosis in an Immunocompetent Patient: A Case Report.

作者信息

Lin Hung-Yi, Lee Wan-Ju Annabelle

机构信息

Medical Education Center, Chi Mei Medical Center, Tainan, Taiwan.

Department of Ophthalmology, Chi Mei Medical Center, Tainan, Taiwan.

出版信息

Front Med (Lausanne). 2022 Jun 29;9:843050. doi: 10.3389/fmed.2022.843050. eCollection 2022.

DOI:10.3389/fmed.2022.843050
PMID:35847774
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9276926/
Abstract

BACKGROUND

This study aimed to report a case who was treated with corticosteroids and anti- parasitic agents for ocular toxoplasmosis, but who progressed to acute retinal necrosis, and finally retinal detachment.

CASE PRESENTATION

A 42-year-old man presented to the ophthalmology clinic with a 1-month history of progressive blurred vision and floaters in his right eye. His best visual acuity (VA) was 20/20 in both eyes. The anterior segment was unremarkable. Funduscopic examination of the right eye revealed active lesions of whitish foci of chorioretinitis with surrounding edema along the superonasal vessels, and retinal vasculitis with perivascular sheathing. Serologic testing was positive for IgM and IgG, but negative for other virus- and syphilis infections. Ocular toxoplasmosis was diagnosed. Corticosteroids and anti-parasitic agents were given simultaneously, but his right eye VA became 20/100. Funduscopic examination revealed retinal necrosis with localized retinal breaks. We immediately performed focal photocoagulation, however, his right eye progressed to retinal detachment and required vitrectomy.

CONCLUSION

Early administration of systemic corticosteroids in patients with acquired acute ocular toxoplasmosis may lead to complications that impair vision. Intensive observation should be arranged after corticosteroid use.

摘要

背景

本研究旨在报告一例接受皮质类固醇和抗寄生虫药物治疗眼部弓形虫病,但病情进展为急性视网膜坏死,最终导致视网膜脱离的病例。

病例介绍

一名42岁男性因右眼进行性视力模糊和飞蚊症1个月就诊于眼科门诊。他双眼的最佳视力(VA)均为20/20。眼前节无异常。右眼眼底检查发现沿鼻上血管有脉络膜视网膜炎白色病灶的活动性病变,周围有水肿,以及视网膜血管炎伴血管周围鞘膜。血清学检测IgM和IgG呈阳性,但其他病毒和梅毒感染检测为阴性。诊断为眼部弓形虫病。同时给予皮质类固醇和抗寄生虫药物治疗,但他右眼的视力降至20/100。眼底检查发现视网膜坏死并伴有局限性视网膜裂孔。我们立即进行了局部光凝治疗,然而,他的右眼进展为视网膜脱离,需要进行玻璃体切除术。

结论

获得性急性眼部弓形虫病患者早期应用全身性皮质类固醇可能导致损害视力的并发症。使用皮质类固醇后应安排密切观察。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ec0/9276926/bc2b629163d4/fmed-09-843050-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ec0/9276926/0117bff47715/fmed-09-843050-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ec0/9276926/bc2b629163d4/fmed-09-843050-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ec0/9276926/0117bff47715/fmed-09-843050-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ec0/9276926/bc2b629163d4/fmed-09-843050-g002.jpg

相似文献

1
The Role of Corticosteroids in Treating Acute Ocular Toxoplasmosis in an Immunocompetent Patient: A Case Report.皮质类固醇在免疫功能正常患者急性眼部弓形虫病治疗中的作用:一例报告
Front Med (Lausanne). 2022 Jun 29;9:843050. doi: 10.3389/fmed.2022.843050. eCollection 2022.
2
Toxoplasmosis chorioretinitis mimicking acute retinal necrosis associated with local corticosteroid.模仿急性视网膜坏死并与局部皮质类固醇相关的弓形虫脉络膜视网膜炎
Int J Retina Vitreous. 2020 Jun 3;6:21. doi: 10.1186/s40942-020-00225-0. eCollection 2020.
3
Presumed toxoplasmic central retinal artery occlusion and multifocal retinitis with perivascular sheathing.疑似弓形体性视网膜中央动脉阻塞及伴有血管周围鞘膜的多灶性视网膜炎。
Clin Ophthalmol. 2014 Apr 23;8:789-92. doi: 10.2147/OPTH.S58669. eCollection 2014.
4
ATYPICAL FORMS OF EYE TOXOPLASMOSIS IN CHILDHOOD. CASE REPORTS.儿童眼弓形体病的非典型形式。病例报告。
Cesk Slov Oftalmol. 2022 Summer;78(5):258-270. doi: 10.31348/2022/27.
5
Acute retinal necrosis in a patient on immunosuppressive treatment for COVID-19 pneumonia: a case report.COVID-19 肺炎免疫抑制治疗患者的急性视网膜坏死:病例报告。
BMC Ophthalmol. 2022 Nov 30;22(1):462. doi: 10.1186/s12886-022-02692-5.
6
A case of ocular toxoplasmosis imaged with spectral domain optical coherence tomography.1例经光谱域光学相干断层扫描成像的眼弓形虫病病例。
Korean J Ophthalmol. 2012 Feb;26(1):58-60. doi: 10.3341/kjo.2012.26.1.58. Epub 2012 Jan 14.
7
Ocular Toxoplasmosis Presenting as Subretinal Macrocyst.表现为视网膜下大囊肿的眼部弓形虫病
J Ophthalmic Vis Res. 2019 Apr-Jun;14(2):223-225. doi: 10.4103/jovr.jovr_210_16.
8
Macular pucker, an atypical clinical presentation of ocular toxoplasmosis: a case report.黄斑皱缩,眼弓形体病的非典型临床表现:一例报告。
BMC Ophthalmol. 2021 May 17;21(1):222. doi: 10.1186/s12886-021-01983-7.
9
PRESUMED FOVEAL BACILLARY LAYER DETACHMENT IN A PATIENT WITH TOXOPLASMOSIS CHORIORETINITIS AND PACHYCHOROID DISEASE.弓形虫脉络膜视网膜炎和肥厚性脉络膜病变患者的推测中心凹内脉络膜层脱离。
Retin Cases Brief Rep. 2021 Jul 1;15(4):391-398. doi: 10.1097/ICB.0000000000000817.
10
Seronegative ocular toxoplasma panuveitis in an immunocompetent patient.免疫功能正常患者的血清阴性眼弓形虫全葡萄膜炎。
Am J Ophthalmol Case Rep. 2020 May 15;19:100745. doi: 10.1016/j.ajoc.2020.100745. eCollection 2020 Sep.

本文引用的文献

1
Pathogenesis of ocular toxoplasmosis.眼弓形体病的发病机制。
Prog Retin Eye Res. 2021 Mar;81:100882. doi: 10.1016/j.preteyeres.2020.100882. Epub 2020 Jul 24.
2
Corticosteroids as adjuvant therapy for ocular toxoplasmosis.皮质类固醇作为眼部弓形虫病的辅助治疗
Cochrane Database Syst Rev. 2017 Jan 26;1(1):CD007417. doi: 10.1002/14651858.CD007417.pub3.
3
Recent Developments in the Diagnosis and Treatment of Ocular Toxoplasmosis.眼部弓形虫病诊断与治疗的最新进展
Ophthalmic Res. 2017;57(1):1-12. doi: 10.1159/000449169. Epub 2016 Oct 11.
4
Fulminant Ocular Toxoplasmosis: The Hazards of Corticosteroid Monotherapy.暴发性眼弓形体病:皮质类固醇单药治疗的危害。
Ocul Immunol Inflamm. 2016 Dec;24(6):637-646. doi: 10.3109/09273948.2015.1057599. Epub 2015 Dec 8.
5
Current Therapy of Acquired Ocular Toxoplasmosis: A Review.获得性眼部弓形虫病的当前治疗方法:综述
J Ocul Pharmacol Ther. 2015 Nov;31(9):511-7. doi: 10.1089/jop.2015.0059. Epub 2015 Jul 30.
6
Ocular Toxoplasmosis.眼部弓形虫病
Ocul Immunol Inflamm. 2015 Jun;23(3):191-3. doi: 10.3109/09273948.2015.1051360.
7
Ocular toxoplasmosis: recent aspects of pathophysiology and clinical implications.眼部弓形虫病:病理生理学的最新进展及临床意义
Ophthalmic Res. 2014;52(3):116-23. doi: 10.1159/000363141. Epub 2014 Sep 19.
8
Therapy for ocular toxoplasmosis--the future.眼弓形体病的治疗——未来。
Ocul Immunol Inflamm. 2013 Aug;21(4):300-5. doi: 10.3109/09273948.2013.779724. Epub 2013 Apr 25.
9
Interventions for toxoplasma retinochoroiditis: a report by the American Academy of Ophthalmology.干预弓形虫视网膜炎:美国眼科学会的报告。
Ophthalmology. 2013 Feb;120(2):371-8. doi: 10.1016/j.ophtha.2012.07.061. Epub 2012 Oct 11.
10
Ocular toxoplasmosis II: clinical features, pathology and management.眼弓形体病 II:临床特征、病理学和治疗。
Clin Exp Ophthalmol. 2013 Jan-Feb;41(1):95-108. doi: 10.1111/j.1442-9071.2012.02838.x. Epub 2012 Sep 17.